Volitionrx (VNRX) Income towards Parent Company (2012 - 2026)

Volitionrx (VNRX) has reported Income towards Parent Company for 11 consecutive years, with -$4.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income towards Parent Company fell 16425.05% year-over-year to -$4.9 million; the trailing twelve-month figure through Jun 2026 stood at -$4.6 million (up 7.67% YoY), and the FY2025 full-year result was $146302.0, down 49.58% from the prior year.
• Income towards Parent Company fell to -$4.9 million in Q2 2026 per VNRX's latest filing, from $260595.0 in the prior quarter.
• Across five years, Income towards Parent Company topped out at $516444.0 in Q4 2024 and bottomed at -$9.5 million in Q2 2023.
• Historically, Income towards Parent Company has averaged -$4.0 million across 5 years, with a median of -$4.9 million in 2026.
• The sharpest annual moves came in 2022 and 2026: Income towards Parent Company soared 791.1% in 2022, then slumped 16425.05% in 2026.
• Over 5 years, Income towards Parent Company stood at -$7.2 million in 2022, then decreased by 20.58% to -$8.7 million in 2023, then soared by 105.91% to $516444.0 in 2024, then tumbled by 49.54% to $260595.0 in 2025, then plunged by 1978.86% to -$4.9 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$4.9 million, $260595.0, and -$31433.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.